Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1660-2862|7|1-3|139-142

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.1-3, 2010-03, pp. : 139-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 403-405

Karger

Access to resources Recommend Favorite

Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 4, 2010-05 ,pp. : 251-259

Karger

Access to resources Recommend Favorite

Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease

By  

Neurodegenerative Diseases, Vol. 16, Iss. 3-4, 2015-11 ,pp. : 284-289

Karger

Access to resources Recommend Favorite

Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-09 ,pp. : 151-153

Karger

Access to resources Recommend Favorite